Good morning, it's Paul and Roland here, with the SCVR for Friday. Today's report is now finished, have a lovely weekend!

Agenda -

Paul's Section:

Seraphine (LON:BUMP) - (from y'day) - a profit warning just after 2 months of listing - is this a record? I have a rummage through its prospectus, and conclude this is actually quite an interesting business - supplying niche maternity clothing. Supply chain delays from China caused a shortage of stock in July & August. That's since been fixed. A buying opportunity maybe?

Safestyle Uk (LON:SFE) - (from y'day) - excellent interim results from this double glazing company. Not a sector I would consider, but for people who do, then this share could be worth a closer look.

In Style (LON:ITS) - Trading update that starts well, and gradually turns into a profit warning! Supply chain problems (not a surprise) and much higher customer returns are given as reasons. Underlying demand looks strong though. Impossible to value, given the absence of proper guidance.

Roland's Section:

Judges Scientific (LON:JDG) - Excellent results from this scientific instrument firm, showing a decent recovery. But the shares are trading at a historically strong valuation, suggesting to me that the shares may be up with events.

Mission (LON:TMG) - This marketing group has delivered a solid set of half-year results, suggesting the business is getting back on track. Although profits are normally weighted to the second half of the year, I think this stock could offer value at current levels.

Explanatory notes -

A quick reminder that we don’t recommend any stocks. We aim to cover trading updates & results of the day and offer our opinions on them as possible candidates for further research if they interest you. Our opinions will sometimes turn out to be right, and sometimes wrong, because it's anybody's guess what direction market sentiment will take & nobody can predict the future with certainty.

We stick to companies that have issued news on the day, with market caps up to about £700m. We avoid the smallest, and most speculative companies, and also avoid a few specialist sectors (e.g. natural resources, pharma/biotech).

A key assumption is that readers DYOR (do your own research), and make your own investment decisions. Reader comments are welcomed - please be civil,…

Unlock the rest of this article with a 14 day trial

or Unlock with your email

Already have an account?
Login here